Saturday, July 11, 2026

pharma · B-cell Acute Lymphoblastic Leukemia

Zhujiang Hospital

Zhujiang Hospital clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Zhujiang Hospital projects

1 ClinicalTrials.gov programs sponsored by Zhujiang Hospital.

Zhujiang Hospital has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CD19 CAR T-Cell(CAT19T2)

    Zhujiang Hospital

    B-cell Acute Lymphoblastic Leukemia

    phase 2 mab terminated

    1 trial

Frequently asked questions

How many clinical projects does Zhujiang Hospital have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.